{"name":"Day One Biopharmaceuticals, Inc.","slug":"day-one-biopharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQeGtYeW1Zb29SVmFESkQxUzVhWmlJWG9jRDVKbHgtY2RXMlBPalBBZVFDZi1keXg3V3otSlFWSFJ6VkpRbDZiSHZJME9jVFRfNkhINnM4b3M3OWJaQWpqZi1IajFNZ1h4SXpxYVctUDdGckpmRW1XVUtmcVNCdG1Qd0ZvelFKVUs2ZEpDNXhMd2FNcng4VUhxcWtkZFZWbzhISl9fcDZwTnd1SmV4N3pJYzQyeGU5WUdFXy04VURwdm9jakE?oc=5","date":"2026-03-26","type":"deal","source":"Stock Titan","summary":"Servier (DAWN) offers $21.50 in cash to buy Day One Biopharma shares - Stock Titan","headline":"Servier (DAWN) offers $21.50 in cash to buy Day One Biopharma shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFA4Q1dzc2NwdFVJU2JaenZEc2k4aDkzaVlHaDZQSDlFOEJjUk1MeHh1Z0VYWjdMREdqYVR2TGpkU2w0YkRadWJJNWh6TFV1aWF2TXVWeVNtR2pNQ3JUR0l6Z2VaYzNQdmJEZEtCVXMtVHFNM3RoT0dz?oc=5","date":"2026-03-06","type":"deal","source":"statnews.com","summary":"Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B - statnews.com","headline":"Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxNcGdTN2lIOWt1a0dsOU9Cc3ZjVnJyRGc2Z0xjYWY2dmRUV1lHLVVYX1RVa0xhZWNpQ3RxdmhYZlBTUnYwRHlPVFRRZTVZWF9WcUNhRzZLa0JRZzRDTTk5bnNFTUtmaDQtcGFZUGtNdFRDUkxSN3ZNakJMZ1dZTGVKNWR3MS1aVWJoODFtajE4ZDBCd3RyN0hOQUN4U2RDeW80OHlEZjFKUmtSeEwtb1RkYmlLbnNFcjJVX01ZcUo5TVBqYnFxVTlJaUVWemhCYmp2ZGJmYnVJWXZHU3Fic2E4TWIyQnRPc18zaXc4Z25VTEFMMXJQM09CUEdadFVDcVJSc1VlWW13?oc=5","date":"2026-03-06","type":"pipeline","source":"GlobeNewswire","summary":"Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio - GlobeNewswire","headline":"Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQSm9aZGJmajdCWGxiX3o1dGk0SFNtUVpfWG81bjlDQUNkUGpSWlFrRnpmU2lYeFBHeUVVSFhMa21ZdHpJazk3NUhKU3RkVmFmRFZhRXNjTkg5TVVPMzU4dnE2bEZxNXJ1bU5ieEhhUjl0N2pKSHd4TWQ4bHQ2SElUbjk4WmI0Y0FTelEzZg?oc=5","date":"2026-03-06","type":"pipeline","source":"Barron's","summary":"Day One Biopharmaceuticals Is Being Bought for $2.5 Billion. Its Stock Is Jumping. - Barron's","headline":"Day One Biopharmaceuticals Is Being Bought for $2.5 Billion. Its Stock Is Jumping. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQd2lXbmFwejhYRlRFVERaY29kNVRKUXRRSmMxanRoWldXc3ZlWDcxNEU3OFJJOXpKSnZKdGVPak1IeWtZeWpCSlZQbzJkaVlHYnRtOVlNOC12ZXo4eVBVaFdELW5yQXFLc0RYOEhTRXEzWnlpNUpuem5lR3JGX2NBSjl4bk0zaWZXWE9MODktMmRxMjBZaWQ4Q3FzNnRQZ3pXeEd4SEktZGRPc0JNT1JDejlzODBnMy1NNGkzc0FrRTl1UQ?oc=5","date":"2026-03-06","type":"deal","source":"Reuters","summary":"Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push - Reuters","headline":"Servier to buy Day One Biopharma for $2.5 billion in tumor treatment push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPQTh2Z3Z6SGN2a2xZQ1c5eEZtb3NycHJ1d0tpRU1Ic0dGdXdITkhhRldqZ3RaV3JtazlLcGdNMk1iUE1GbGgxVTMxTTl4SWxkT3A4eDV6NkxacklpaVhwOW51WnBDc3lMRnlVd0l6UEtidVhHRElUTDl1aTJST2ZpYg?oc=5","date":"2026-03-06","type":"deal","source":"seekingalpha.com","summary":"Day One Biopharma to be acquired by Servier for $2.5B - seekingalpha.com","headline":"Day One Biopharma to be acquired by Servier for $2.5B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPUWRpLW05cHNidTRLTmNjT3pfXzh6OU1za3pIQzl1Ujc5aDVILUhHdGN2VVEzMjhsRzhBSTZzN19rVHFLS19pUDZPeGs2Q3RrM0k2TmkwSG1kQno5WlhFLXRzNnNmLXdrY0ExZW1NazdxYXBTQ25LeUpqWHFnbEdKUFIya0hycmY0OG1jLUFpNGdlZ0ZxUWZ2R0RYRll1dDJZR3oyZ0xER3lMWGlIRzI2b2FsaWJ0WXcyRjlpVl9qNXk?oc=5","date":"2026-03-06","type":"deal","source":"Contract Pharma","summary":"Servier Acquires Day One Biopharmaceuticals, Expanding Rare Oncology Portfolio - Contract Pharma","headline":"Servier Acquires Day One Biopharmaceuticals, Expanding Rare Oncology Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOcWRJN3ZQVkMwX2Nad0VDcDIwNDRUQnlNbGJfdFlSUTZIalBoNkhTNGVORWZlMXliT1AxNXZEdkR6SUFzclpGV3hPdlQ3eWt5T1hZenlLY3J6c1RlZ0Z5aVNNbTBDTXhXZVZQbzNZcUM1RmpTbjBYaWpyemFlb01HUnJXVWRJTVRyQnNoeFdvbnR5YmFhNmNiMlNRbFdLcmxVd2p0MDJCWWRTR2hVRlBuZFFobnVoOGZObzkxMzZB?oc=5","date":"2026-03-06","type":"deal","source":"Fierce Pharma","summary":"Servier to widen rare cancer offerings with $2.5B buyout of Day One and glioma drug Ojemda - Fierce Pharma","headline":"Servier to widen rare cancer offerings with $2.5B buyout of Day One and glioma drug Ojemda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOY2FyYTFQeWJpZUIxUWlzRC1HNGkycHllWlhubC1hVWlLMnpQNzFZSW9ZWmVVWFo1cUZrTEpsaFd2YWxsb0dDMzhIS0xZanZLSkNBTGZyQmRsUXc1b3FMX29VUEVHdWNWaHVUR2s0ZTIzdFVGRlRlWlhBeUJWaDd6b09mZlVLSk9CRGd1NTk3a2FYTFNuajJKdTV6VWc3cnZaUmMxM19INA?oc=5","date":"2026-03-06","type":"pipeline","source":"BioPharma Dive","summary":"Servier to build cancer drug pipeline with $2.5B purchase of Day One - BioPharma Dive","headline":"Servier to build cancer drug pipeline with $2.5B purchase of Day One","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRjNYQllJdXFlc0ZBOXlnMVlLcUFqQzJINnpEZUpVWTZyZ2lSamNwVG0zb3RSR2kzdjVSRmlJNkp1VGsydGNOUUY1LUZjMHR0blAzOE51MWZPUmNDUFp6S2JRdFFYb1lWdXQyTnlnenZHS0RQVmF3S3p4UGM0ekJ5ZWJMVlVPUlVydzlubVdJODFyR2Nzd09VeXZYU1Q4aW91QUVfeWtB?oc=5","date":"2026-03-06","type":"deal","source":"BioSpace","summary":"Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy - BioSpace","headline":"Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNbGhEQVhjTnk1SURmTk1MV1NreEpjS0QzejVFdkdWYno0aXZjOFZBc2VKTjNsQ0RhT05jazhMaXlTekZkbk0tdmd1dlNtUWtDYk5LUFVwUmlEZkFLZVFJa1ozdUcyRE1xeGhXTG1tc3NOSVZPRnVDc0VEWHlYbW0wY2FGSzcwOUxtUl9WSHdaLV94V0x6dV9wY1p2dG8zYXpEU2lqbG41Nl83OXJp?oc=5","date":"2026-03-06","type":"regulatory","source":"The Business Journals","summary":"How a Bay Area company won a drug approval and a $2.5 billion buyout in eight years - San Francisco Business Times - The Business Journals","headline":"How a Bay Area company won a drug approval and a $2.5 billion buyout in eight years - San Francisco Business Times","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-01-21","type":"pipeline","source":"simplywall.st","summary":"Optimistic Investors Push Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Up 31% But Growth Is Lacking - simplywall.st","headline":"Optimistic Investors Push Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Up 31% But Growth Is Lacking","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}